Latest profit margin for Myomo: -33.53% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for MYO is -33.53% as of June 2026. That compares with -22.87% in the prior-year period — down 46.6% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Myomo's historical trend and sector peers before judging valuation or financial health.
Over the past year, MYO's profit margin moved from -22.87% to -33.53% — a 46.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Myomo's valuation or profitability profile.
Against Healthcare companies, MYO currently prints -33.53% for profit margin, while the sector average sits near 14.34%. That is roughly 333.8% below the sector mean. Large gaps often invite a closer look at Myomo's growth, margins, and balance sheet.
Profit Margin shows how effectively Myomo converts resources into returns. At -33.53%, MYO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -22.87% in the prior-year period — down 46.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MYO's profit margin (-33.53%), review year-over-year change from -22.87%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.